Biospecimen Integrity Assessment via Protein Oxidation Markers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing the integrity of biobanked human cell, tissue, or blood plasma and serum samples are inadequate due to instability and lack of reliable quality control tools that consider the molecular root cause of protein oxidation, leading to potentially invalid results.
Innovation Solution
The development of methods and systems for detecting biospecimen integrity through quantifying protein oxidation, specifically using S-cysteinylated albumin (S-Cys-Alb) and methionine-oxidized apolipoprotein A-I (MOA1) as markers, which measure the difference in protein oxidation before and after intentional incubation to determine the degree of ex vivo oxidation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If biobanked samples are stored at common laboratory freezer temperatures (−20° C.), then ease of operation is improved, but protein oxidation occurs leading to loss of sample integrity
Solution Approach 1:
The patent applies preliminary action by adding antioxidants (such as vitamin C, vitamin E, or other reducing agents) to the biospecimen samples at the time of collection and processing. This preemptive measure prevents oxidation from occurring during subsequent storage at −20° C., allowing the samples to be stored at convenient temperatures without compromising integrity. The antioxidants are incorporated into the sample matrix before storage, creating a protective environment that maintains protein stability throughout the storage period.
2Reliability
If samples are stored at −80° C. to prevent oxidation, then sample integrity is improved, but device complexity and energy consumption increase
Solution Approach 1:
The patent changes the chemical parameter of the storage environment by introducing antioxidants that alter the oxidation-reduction potential of the sample matrix. This chemical modification allows samples to maintain stability at higher temperatures (−20° C.) rather than requiring ultra-low temperature storage (−80° C.). The antioxidants create a reducing environment that prevents protein oxidation, effectively changing the stability parameters of the biospecimens to permit more practical storage conditions.
3Ease of operation
If existing markers based on quantitative loss of target protein are used, then ease of operation is improved, but measurement precision deteriorates because they do not consider molecular root cause
Solution Approach 1:
The patent replaces the mechanical/empirical measurement approach (quantifying protein loss) with a molecular mechanism-based approach (detecting oxidation-specific modifications). Instead of simply measuring whether protein levels have decreased, the method uses mass spectrometry to detect specific oxidation markers such as carbonyl groups, sulfonic acid derivatives, or other oxidative modifications on amino acid residues. This substitution of measurement methodology provides direct evidence of oxidation damage at the molecular level, enabling precise assessment of sample integrity based on the actual chemical damage mechanism rather than indirect proxies.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These markers provide a mechanism-based assessment of sample integrity, allowing for the detection of molecular damage caused by improper handling and storage, ensuring the validity of clinical research by identifying samples that have been mistreated or exposed to non-ideal conditions.
Implementation Method 1
assessing ex vivo oxidation of a biospecimen sample by quantifying a difference in protein oxidation of the biospecimen sample in comparison to protein oxidation of a portion of the biospecimen sample intentionally incubated to cause oxidation to hit its maximum value
Data Source
AI summary
Methods for quantifying biospecimen sample integrity using oxidation. Embodiments include assessing ex vivo oxidation of a biospecimen sample by quantifying a difference in protein oxidation of the biospecimen sample in comparison to protein oxidation of a portion of the biospecimen sample intentionally incubated to cause oxidation to hit its maximum value. The difference in a level of oxidation in the biospecimen sample and the portion of the biospecimen sample is then inversely proportional to the degree of ex vivo oxidation.


